Free tool
Drug Search
Every brand-name drug and biologic application (NDA or BLA) in Drugs@FDA: 5,899 in all. Generic (ANDA) applications are not listed; their reference drug is.
Last checked: Nov 20, 2026Drugs@FDA last updated: Nov 18, 2026Methods & limitations
6 matches for "Vanda Pharms INC"
Brand names that start with your search come first, then marketed and novel drugs.
| Drug | Sponsor | Application | First approved | Programs |
|---|---|---|---|---|
| Nereus Tradipitant | Vanda Pharms INC | NDA220152 | Dec 30, 2025 | Novel |
| Fanapt Iloperidone | Vanda Pharms INC | NDA022192 | May 6, 2009 | Novel |
| Hetlioz Tasimelteon | Vanda Pharms INC | NDA205677 | Jan 31, 2014 | NovelPriority reviewOrphan |
| Bysanti Milsaperidone | Vanda Pharms INC | NDA220358 | Feb 20, 2026 | Novel |
| Ponvory Ponesimod | Vanda Pharms INC | NDA213498 | Mar 18, 2021 | Novel |
| Hetlioz Lq Tasimelteon | Vanda Pharms INC | NDA214517 | Dec 1, 2020 | Priority reviewOrphan |
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.